ARCHIVES

CMS also decided to cover off-label uses of approved colorectal cancer drugs in clinical trials, and allowed broader use of PET scans.

This article is from The Cancer Letter archive.

Vol. 30 No. 42 | November 5, 2004

Download PDF Visit The Full Archive

Related Articles

Phase II Study of Veliparib Improves PFS by 35 Percent

October 31, 2014

Virus Cancer Program Report On Scientific Activities

August 1, 1975

In Brief: Anderson Assumes ACCC President, Enck President Elect; Reagan Reappoints Montgomery

April 11, 1986

Wyden Asks Healy To Clarify CRADA Pricing Clause

January 3, 1992

James Abbruzzese Moves to Duke Cancer Institute

September 27, 2013

NIH Entertainment: Wild Type Wins First, The Directors Second, In Battle of Bands

October 15, 1999